Detour II Study
Research payments
$157,834
Through program year 2022, $157,834 in research payments was reported against Detour II Study, across 70 payments, paid by Endologix, Inc..
- Paid by
- Endologix, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $117,599 | 56 |
| 2021 | Research | $40,235 | 14 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Vasili Lendel Little Rock, AR Named on 6 payments
- Barry Tedder Jonesboro, AR Named on 6 payments
- Ajanta De Mountain View, CA Named on 6 payments
- Peter Soukas Providence, RI Named on 4 payments
- Bruce Gray Greenville, SC Named on 4 payments
- Richard Wilkerson Albuquerque, NM Named on 4 payments
- John Corl Cincinnati, OH Named on 4 payments
- Jonathan Bowman Stratford, CT Named on 4 payments
- Brack Hattler Aurora, CO Named on 3 payments
- Jihad Mustapha Grand Rapids, MI Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.